Laurie's Story on Living with Ulcerative Colitis - Bristol Myers Squibb
December 20, 2023
One woman's account of living with ulcerative colitis >
Doing R&D “Differently” to Transform Treatment for Serious Diseases
May 28, 2023
Doing R&D "differently" to transform treatment for serious diseases >
My front row seat to the revolution in immune checkpoint inhibition
April 30, 2023
My front row seat to the revolution in immune checkpoint inhibition >
Dana Walker, MD, MSCE, vice president and Global Program Lead, Genitourinary Cancers, at Bristol Myers Squibb
February 05, 2023
Reflecting on research in genitourinary cancers >
January 24, 2023
The power of dual immunotherapy >
Lee James, MD, PhD, vice president of U.S. Medical Oncology at Bristol Myers Squibb
November 01, 2022
Lung cancer is personal: Interview with Lee James >
Healthcare professionals
March 31, 2022
The quest to stop cancer from coming back  >
CD47 embedded in the cell membrane
December 07, 2021
Pulling back the curtain on CD47 >
Mixed race healthcare professionals
October 28, 2021
Experts weigh in: immunotherapy in earlier stages of cancer >
Asian scientist with microscope
August 20, 2021
The surprising science that connects immunology and oncology >
Kald Abdallah, senior vice president of Worldwide Medical Oncology
May 17, 2021
Kald Abdallah, driven by a personal passion, wants to discover ways to treat cancer earlier >
Ian M. Waxman, MD., Development Program Lead, Gastrointestinal Cancers, reflects on recent advancements validating the role of immunotherapy in the adjuvant setting
September 07, 2020
Addressing cancer earlier >